Effect of pharmacotherapy on serum cholesterol levels in patients with panic disorder

Acta Psychiatrica Scandinavica

Volumn 93, Issue 3, 1996, Pages 164-167

  Shioiri, T ^a   Fujii, K ^a   Someya, T ^a   Takahashi, S ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

agoraphobia; benzodiazepine; cardiovascular disease; cholesterol; panic disorder

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHOLESTEROL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL;

EID: 0029943719     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb10624.x     Document Type: Article

References (16)

1. DREYFUSS F, CZACZKES J. Blood cholesterol and uric acid of healthy medical students under the stress of an examination. Arch Intern Med 1958: 103: 708-711.
2. GOODMAN JR, KELLOGG F, PORTER RW, LEICHTI R. Decrease in serum cholesterol with surgical stress. Calif Med 1962: 97: 278-280.
3. PETERSON J, KEITH R, WILCOX A. Hourly changes in serum cholesterol. Circulation 1962: 25: 798.
4. DIMSDALE JE, HERD JA. Variability of plasma lipids in response to emotional arousal. Psychosom Med 1982: 44: 413-430.
5. BAJWA WK, ASNIS GM, SANDERSON WC, IRFAN A, VON PRAAG HM. High cholesterol levels in patients with panic disorder. Am J Psychiatry 1992: 149: 376-378.
6. CORYELL W, NOYES R, CLANCY J. Excess mortality in panic disorder. Arch Gen Psychiatry 1982: 39: 701-703.
7. WEISSMAN MM, MARKOWITZ JS, OUELLETTE R, GREENWALD S, KAHN JP. Panic disorder and cardiovascular/ cerebrovascular problems: results from a community survey. Am J Psychiatry 1990: 147: 1504-1508.
8. HAYWARD C, TAYLOR CB, ROTH WT, KING R, AGRAS WS. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry 1989: 146: 917-919.
9. TANCER ME, STEIN MB, MOUL DE et al. Normal serum cholesterol in panic disorder. Biol Psychiatry 1990: 27: 99-101.
10. REIFMAN A, WINDLE M. High cholesterol levels in patients with panic disorder (letter). Am J Psychiatry 1993: 150: 527.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd edn, revised. Washington, DC: American Psychiatric Association, 1987.
12. CORYELL W. Panic disorder and mortality. Psychiatr Clin North Am 1988: 11: 433-440.
13. TAYLOR CB, HAYWARD CH, KING R et al. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. J Clin Psychopharmacol 1990: 10: 112-118.
14. FEDER R. High cholesterol levels in patients with panic disorder (letter). Am J Psychiatry 1993: 150: 527.
15. CROWE RR, NOYES R, PAULS DL, SIYMEN D. A family study of panic disorder. Arch Gen Psychiatry 1983: 40: 1065-1069.
16. BRAESTRUP C, NIELSEN M. Benzodiazepine receptors. In: IVERSON L et al., ed. Handbook of psychopharmacology. New York: Plenum, 1983: 285-384.